The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data.

Penson DF, Moul JW, Evans CP, Doyle JJ, Gandhi S, Lamerato L
J Urol. 2004 171 (6 Pt 1): 2250-4

PMID: 15126796 · DOI:10.1097/01.ju.0000127732.63726.4c

MeSH Terms (11)

Adult Aged Aged, 80 and over Cost of Illness Disease Progression Humans Male Middle Aged Prostate-Specific Antigen Prostatic Neoplasms Retrospective Studies

Connections (1)

This publication is referenced by other Labnodes entities: